Day: May 23, 2024

SHENZHEN, China, May 23, 2024 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that it will release its unaudited financial results for the first quarter ended March 31, 2024 before the open of U.S. markets on Thursday, June 6, 2024. Aurora Mobile’s management will host an earnings conference call on Thursday, June 6, 2024 at 7:30 a.m. U.S. Eastern Time (7:30 p.m. Beijing time on the same day). All participants must register in advance to join the conference using the link provided below. Please dial in 15 minutes before the call is scheduled to begin. Conference access information will be provided upon registration. Participant Online Registration: https://register.vevent.com/register/BI6b9a5e81258648acbe3cdaf41598ad70 A...

Terranet AB (publ) (”Terranet” or the “Company”) hereby announces the Board and management of the Company, as well as companies affiliated with them, intend to exercise their warrants of series TO7, an investment of approximately SEK 3.6 million, corresponding to approximately 27 percent of the total amount of outstanding warrants of series TO7. The subscription period for the warrants of series TO7 is currently ongoing and will continue up until June 3, 2024. The Board and management of the Company, as well as companies affiliated with them, intend to exercise their warrants of series TO7 as detailed below:Name Position Subscribed amount, number of TO7 Subscribed amount, SEKMaida Vale Capital AB Major shareholder 47,358,858 3,457,197Magnus Andersson CEO 833,331 60,833Anders Blom Member of the Board 520,000 37,960Torgny...

                 Press Release Eviden wins 2nd place in the world’s largest cyber defense exercise Eviden Poland team, part of the international Poland-Finland team, is on podium for second year in a row Paris, May 23, 2024 – Eviden, the Atos Group business leading in digital, cloud, big data and security today announces that four of its cybersecurity experts based in Poland and two in Romania have participated in the largest international cyber defense exercise, “Locked Shields 2024”, organized by the NATO Cooperative Cyber Defense Center of Excellence (CCDCOE) . Due to the company’s capabilities and the expertise of its people, Eviden representatives from Poland contributed to the Poland-Finland team that was awarded 2nd place, following on from Poland’s 3rd place ranking last year. This year also marks the 2nd...

PRESS RELEASE Share Buyback Transaction Details May 16 – May 22, 2024 Alphen aan den Rijn – May 23, 2024 – Wolters Kluwer (Euronext: WKL), a global leader in professional information, software solutions, and services, today reports that it has repurchased 142,727 of its own ordinary shares in the period from May 16, 2024, up to and including May 22, 2024, for €20.9 million and at an average share price of €146.74. These repurchases are part of the share buyback program announced on February 21, 2024, under which we intend to repurchase shares for €1 billion during 2024. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2024Period Cumulative shares repurchased in period Total consideration(€ million) Average share price(€)2024 to date 2,911,319 414.6 142.43For...

Oslo, 23 May 2024. PCI Biotech Holding ASA (“PCI Biotech” or the “Company”) issue this notification on behalf of Hans Peter Bøhn, Chair of the Board of Directors. Hans Peter Bøhn is chair of PCI Biotech’s board of directors and shall open the annual general meeting of the Company on 24 May 2024. Mr. Bøhn holds 123,662 shares, representing 0.3 percent of the share capital of PCI Biotech. Mr. Bøhn has received powers of attorney to represent and vote for 4,288,185 additional shares. In total, Mr. Bøhn will represent and vote for 11.8 percent of the share capital. A major part of the powers of attorney are without voting instructions. The powers of attorney are only valid at the annual general meeting on 24 May 2024. This information is subject to the disclosure requirements pursuant to section 4 -3, cf. section 5-12...

Nature Medicine published Up-LIFT pivotal trial results Submitted FDA De Novo application for ARC-EX® System Successfully raised EUR 20M in equity capital EINDHOVEN, the Netherlands, May 23, 2024 (GLOBE NEWSWIRE) —  ONWARD Medical N.V. (Euronext: ONWD), a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today provided a Q1 2024 business update. “This week’s publication of Up-LIFT pivotal trial results in Nature Medicine underscores the tremendous potential of ARC-EX Therapy to restore independence in daily activities for people with spinal cord injury,” said Dave Marver, CEO of ONWARD Medical. “We are working closely with the FDA toward clearance for the ARC-EX System and we are preparing to introduce this technology...

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL. PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE. On 26 April 2024, the Board of Directors of Fingerprint Cards AB (publ) (“Fingerprints” or the “Company”) announced that the Board of Directors resolved to, subject to subsequent approval by the annual general meeting on 28 May 2024, carry out a partially guaranteed issue of new shares of series B (“B-shares”) of up to approximately SEK 310 million with preferential rights for its existing shareholders (the “Rights Issue”). Today, Fingerprints’...